Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ADGM

Adagio Medical Holdings Inc

Dec 16 • 02:32PM ET

1.09

+0.26 31.12 %

Healthcare • Medical Devices • USA • NASD

Today, 2:01 PMCEO insider purchase and recent strategic funding fueled Adagio Medical's intraday surge.

Peers: BSX STXS EW LXRX NVRO CUTR BLFS CLPT

| Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.28	Insider Own	3.24%	Shs Outstand	21.18M	Perf Week	20.58%
Market Cap	23.09M	Forward P/E	-	EPS next Y	-	Insider Trans	43.28%	Shs Float	20.49M	Perf Month	38.91%
Enterprise Value	40.39M	PEG	-	EPS next Q	-0.31	Inst Own	65.41%	Short Float	1.89%	Perf Quarter	-33.13%
Income	-79.15M	P/S	164.93	EPS this Y	-	Inst Trans	17.99%	Short Ratio	1.05	Perf Half Y	0.00%
Sales	0.14M	P/B	-	EPS next Y	-	ROA	-114.09%	Short Interest	0.39M	Perf YTD	3.81%
Book/sh	-0.09	P/C	4.94	EPS next 5Y	-	ROE	-210.36%	52W High	2.87 -62.02%	Perf Year	-49.18%
Cash/sh	0.22	P/FCF	-	EPS past 3/5Y	-143.50% -816.44%	ROIC	-386.55%	52W Low	0.62 74.40%	Perf 3Y	-89.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-1932.48%	Volatility	19.27% 14.09%	Perf 5Y	-
Dividend TTM	-	EV/Sales	288.50	EPS Y/Y TTM	70.03%	Oper. Margin	-19480.29%	ATR (14)	0.14	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.68	Sales Y/Y TTM	-70.54%	Profit Margin	-57771.53%	RSI (14)	57.02	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.84	EPS Q/Q	-106.53%	SMA20	23.78%	Beta	0.15	Target Price	4.00
Payout	-	Debt/Eq	-	Sales Q/Q	-100.00%	SMA50	-4.96%	Rel Volume	2.18	Prev Close	0.83
Employees	80	LT Debt/Eq	-	Earnings	Dec 03	SMA200	-14.40%	Avg Volume	370.43K	Price	1.09
IPO	Feb 26, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	634,226	Change	31.12%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-25	Initiated	Lake Street	Buy	$4

Dec-11-25 08:00AM	Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors (Business Wire)
Nov-12-25 04:05PM	Adagio Medical Reports Third Quarter 2025 Results (Business Wire)
Oct-20-25 08:00AM	Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia (Business Wire) +5.45%
Oct-15-25 08:00AM	Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities (Business Wire) -19.88%
Oct-10-25 03:40PM	Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium (Business Wire) -13.93%
08:00AM	Loading…
Oct-01-25 08:00AM	Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia (Business Wire)
Sep-18-25 08:00AM	Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium (Business Wire) +11.66%
Sep-08-25 08:00AM	Adagio Medical Expands Chief Business Officer Deborah Kasters Role to Include Chief Financial Officer Responsibilities (Business Wire) -12.03%
Aug-13-25 04:30PM	Adagio Medical Reports Second Quarter 2025 Results (Business Wire)
May-15-25 04:05PM	Adagio Medical Reports First Quarter 2025 Results (Business Wire)
May-07-25 08:30AM	Adagio Medical to Present at the BofA Securities 2025 Health Care Conference (Business Wire)
Apr-17-25 08:30AM	Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System (Business Wire) +92.81%
Mar-31-25 04:01PM	Adagio Medical Appoints Deborah Kaster as Chief Business Officer (Business Wire) -14.36%
08:30AM	Adagio Medical Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Mar-17-25 04:01PM	Adagio Medical Provides Clinical and Business Updates (Business Wire) -7.41% -9.00%
08:30AM	Loading…
Feb-28-25 08:30AM	Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation (Business Wire) -45.94%
Feb-18-25 04:01PM	Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference (Business Wire)
Dec-16-24 08:00AM	Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director (Business Wire) -9.41%
Nov-14-24 04:01PM	Adagio Medical Reports Third Quarter 2024 Results (Business Wire) +57.87% -19.14%
Nov-04-24 04:01PM	Adagio Medical to Present at the Stifel 2024 Healthcare Conference (Business Wire) +7.75%
Oct-24-24 08:30AM	Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System (Business Wire)
Oct-07-24 04:01PM	Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias (Business Wire) -7.14%
Aug-19-24 04:01PM	Adagio Medical Provides Business Updates (Business Wire)

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in Laguna Hills, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Usen Todd	Chief Executive Officer	Dec 12 '25	Buy	1.09	207,315	225,973	207,315	Dec 15 09:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADGM

Adagio Medical Holdings Inc

Upgrade your FINVIZ experience